Cargando…
Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species
Invasive fungal diseases (IFDs) have been widely studied in recent years, largely because of the increasing population at risk. Aspergillus and Candida species remain the most common causes of IFDs, but other fungi are emerging. The early and accurate diagnosis of IFD is critical to outcome and the...
Autores principales: | Drgona, L., Khachatryan, A., Stephens, J., Charbonneau, C., Kantecki, M., Haider, S., Barnes, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892112/ https://www.ncbi.nlm.nih.gov/pubmed/24026863 http://dx.doi.org/10.1007/s10096-013-1944-3 |
Ejemplares similares
-
Empiric/pre-emptive anti-Candida therapy in non-neutropenic ICU patients
por: Timsit, Jean-François, et al.
Publicado: (2015) -
Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System
por: Torres, Antoni, et al.
Publicado: (2022) -
Immunological Aspects of Candida and Aspergillus Systemic Fungal Infections
por: Mueller-Loebnitz, Christoph, et al.
Publicado: (2013) -
The Fungal Cell Wall: Candida, Cryptococcus, and Aspergillus Species
por: Garcia-Rubio, Rocio, et al.
Publicado: (2020) -
Transcriptomics of the Fungal Pathogens, Focusing on Candida albicans
por: Rupp, Steffen
Publicado: (2008)